Illumina, Inc. (ILMN)
NASDAQ: ILMN · IEX Real-Time Price · USD
117.93
-6.06 (-4.89%)
At close: May 3, 2024, 4:00 PM
119.00
+1.07 (0.91%)
After-hours: May 3, 2024, 7:58 PM EDT
Illumina Employees
Illumina had 13,360 employees on December 31, 2023. The number of employees increased by 1,610 or 13.70% compared to the previous year.
Employees
13,360
Change (1Y)
1,610
Growth (1Y)
13.70%
Revenue / Employee
$336,302
Profits / Employee
-$96,482
Market Cap
18.74B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13,360 | 1,610 | 13.70% |
Dec 31, 2022 | 11,750 | 2,400 | 25.67% |
Dec 31, 2021 | 9,350 | 1,500 | 19.11% |
Dec 31, 2020 | 7,850 | 150 | 1.95% |
Dec 29, 2019 | 7,700 | 400 | 5.48% |
Dec 30, 2018 | 7,300 | 1,100 | 17.74% |
Dec 31, 2017 | 6,200 | 700 | 12.73% |
Dec 31, 2016 | 5,500 | 900 | 19.57% |
Dec 31, 2015 | 4,600 | 900 | 24.32% |
Dec 28, 2014 | 3,700 | 700 | 23.33% |
Dec 29, 2013 | 3,000 | 800 | 36.36% |
Dec 31, 2012 | 2,200 | -200 | -8.33% |
Dec 30, 2012 | 2,400 | 300 | 14.29% |
Dec 31, 2011 | 2,100 | 319 | 17.91% |
Dec 31, 2010 | 1,781 | 245 | 15.95% |
Dec 28, 2008 | 1,536 | 495 | 47.55% |
Dec 30, 2007 | 1,041 | 445 | 74.66% |
Dec 31, 2006 | 596 | 221 | 58.93% |
Dec 31, 2006 | 375 | 97 | 34.89% |
Dec 31, 2005 | 278 | 42 | 17.80% |
Dec 28, 2003 | 236 | 3 | 1.29% |
Dec 29, 2002 | 233 | 54 | 30.17% |
Dec 30, 2001 | 179 | 74 | 70.48% |
Dec 31, 2000 | 105 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Baxter International | 60,000 |
Align Technology | 21,610 |
Molina Healthcare | 18,000 |
STERIS | 17,100 |
The Cooper Companies | 15,000 |
BeiGene | 10,600 |
Waters | 7,900 |
Hologic | 6,990 |
ILMN News
- 2 days ago - Illumina To Webcast Upcoming Investor Conference - PRNewsWire
- 3 days ago - Illumina reaffirms annual revenue forecast over continued sluggish demand - Reuters
- 3 days ago - Illumina Reports Financial Results for First Quarter of Fiscal Year 2024 - PRNewsWire
- 23 days ago - Illumina's planned divestment of GRAIL approved by the European Commission - PRNewsWire
- 23 days ago - EU approves Illumina's plan to divest cancer test maker Grail - Reuters
- 26 days ago - Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor - Reuters
- 26 days ago - Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer - PRNewsWire
- 4 weeks ago - Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024 - PRNewsWire